Cytokine profile of cerebrospinal fluid in pediatric patients with metastatic medulloblastoma

The present study investigated cytokine profiles in the CSF of pediatric patients with MB. Our results suggest that these differentially expressed cytokines may serve as novel markers for detecting MB, especially for assessing the risk of progression and metastasis.

Authors

Institutions

Publication Details

Journal
Heliyon
Published
2024-09-26
DOI
https://doi.org/10.1016/j.heliyon.2024.e38504
Citations
2
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cytokine profile of cerebrospinal fluid in pediatric patients with metastatic medulloblastoma

Jie Ma, Haibo Zhang, Yufan Chen, Heng Zhao et al.
2 citations
Heliyon
Glioma Diagnosis and Treatment
0.88
article

Cytokine profile of cerebrospinal fluid in pediatric patients with metastatic medulloblastoma

Jie Ma, Haibo Zhang, Yufan Chen, Heng Zhao, Baocheng Wang
article en
2 citations

Abstract

The present study investigated cytokine profiles in the CSF of pediatric patients with MB. Our results suggest that these differentially expressed cytokines may serve as novel markers for detecting MB, especially for assessing the risk of progression and metastasis.

HeliyonVol. 10(21)
Shanghai Jiao Tong University (CN), XinHua Hospital (CN)
National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 24%
Glioma Diagnosis and Treatment
0.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.